A new chloroquinolinyl chalcone derivatives as inhibitor of inflammatory and immune response in mice and rats

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 9, 2003, Pages 1313-1321

  De Leon E J ^a   Alcaraz, M J ^a   Dominguez, J N ^a   Charris, J ^b   Terencio, M Carmen ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 3 [3 (6,7 DIMETHOXY 2 CHLOROQUINOLINYL)] 2 PROPEN 1 ONE; 1 FLUORO 2,4 DINITROBENZENE; CHALCONE DERIVATIVE; CHLOROQUINOLINYL CHALCONE DERIVATIVE; CYTOKINE; DEXAMETHASONE; FORMALDEHYDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHENYLQUINONE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; ZYMOSAN;

ADJUVANT ARTHRITIS; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; DRUG EFFICACY; EAR DISEASE; EDEMA; EXUDATE; FEMALE; HOT PLATE TEST; IC 50; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MIGRATION INHIBITION; MONONUCLEAR CELL; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PAW EDEMA; RAT; RAT STRAIN;

ABDOMINAL INJURIES; ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; BLOOD PLATELETS; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINITROFLUOROBENZENE; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; FEMALE; FORMALDEHYDE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICROSOMES; NITRITES; PAIN; PAIN MEASUREMENT; PHOSPHOLIPASES A; PYRIDAZINES; RATS; RATS, INBRED LEW; THROMBOXANE B2; ZYMOSAN;

EID: 0141682524     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021747     Document Type: Article

References (41)

1. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., Gregory, S. A. (1996) Selective inhibition of cyclo-oxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97: 2672-2679
2. Babson, A. L., Phillips, G. E. (1965) A rapid colorimetric assay for serum lactic dehydrogenase. Clin. Chim. Acta 12: 210-215
3. Boyum, A. (1976) Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. Suppl. 5: 9-15.
4. 2 synthase inhibitor and receptor antagonist in vitro. Br. J. Pharmacol. 110: 1600-1606
5. Cheng, Z., Lin, C., Hwang, T., Teng, C. (2001) Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol. 61: 939-946
6. Choy, E. H., Panayi, G. S. (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344: 907-916
7. 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. USA 87: 7708-7712
8. Edwards, J. C. W., Sedgwick, A. D., Willoughby, D. A. (1981) The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system. J. Pathol. 134: 147-156
9. 2 associated with rabbit polymorphonuclear leukocyte granules. J. Lipid Res. 15: 380-388
10. Góngora, L., Máñez, S., Giner, R. M., Recio, M. C., Ríos, J. L. (2000) On the activity of trifluoroperazine and palmitoylcarnitine in mice: Delayed hypersensitivity models. Life Sci. 66: 183-188
11. Grabbe, S., Schwarz, T. (1996) Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Am. J. Contact Dermat. 7: 238-246
12. Griswold, D. E., Marshall, P., Martin, L., Webb, E. F., Zabko-Potapovich, B. (1991) Analgesic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism. Agents Actions Suppl. 32: 113-117
13. Gross, S. S., Levi, R. (1992) Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267: 25722-25729
14. Haraguchi, H., Ishikawa, H., Mizutani, K., Tamura, Y., Kinoshita, T. (1998) Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg. Med. Chem. 6: 339-347
15. Herencia, F., Ferrándiz, M. L., Ubeda, A., Domínguez, J. N., Charris, J. E., Lobo, G. M., Alcaraz, M. J. (1998) Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg. Med. Chem. Lett. 8: 1169-1174
16. Herencia, F., Ferrándiz, M. L., Ubeda, A., Guillén, I., Dominguez, J. N., Charris, J. E., Lobo, M. G., Alcaraz, M. J. (1999) Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett. 453: 129-134
17. Herencia, F., Ferrandiz, M. L., Ubeda, A., Guillén, I., Dominguez, J. N., Charris, J. E., Lobo, G. M., Alcaraz, M. J. (2001) 4-Dimethylamino-3′,4′-dimethoxychalcone down-regulates iNOS expression and exerts anti-inflammatory effects. Free. Radic. Biol. Med. 30: 43-50
18. Holmdahl, R., Klareskog, L., Rubin, K.., Larsson, E., Wigzell, H. (1985) Lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand. J. Immunol. 22: 295-306
19. Hsieh, H. K., Tsao, L. T., Wang, J. P., Lin, C. N. (2000) Synthesis and anti-inflammatory effect of chalcones. J. Pharm. Pharmacol. 52: 163-171
20. Huang, Y. C., Guh, J. H., Cheng, Z. J., Chang, Y. L., Hwang, T. L., Lin, C. N., Teng, C. M. (2001) Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells. Life Sci 68: 2435-2447
21. Hunskaar, S., Hole, K. (1987) The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114
22. Kang, R. Y., Freire Moar, J., Sigal, E., Chu, C. Q. (1996) Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheumatol. 35: 711-718
23. Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., O'Neill, G. (1996) Characterization of prostaglandin g/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111: 445-454
24. Kaur, H., Halliwell, B. (1994) Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350: 9-12
25. Laskin, D. L., Pendino, K. J. (1995) Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35: 655-677
26. Li, R., Kenyon, G. L., Cohen, F. E., Chen, X., Gong, B., Dominguez, J. N., Davidson, E., Kurzban, G., Miller, R. E., Nuzum, E. O. (1995) In vitro antimalarial activity of chalcones and their derivatives. J. Med. Chem. 38: 5031-5037
27. Madan, B., Batra, S., Ghosh, B. (2000) 2′-Hydroxychalcone inhibits nuclear factor-kappaB and blocks tumor necrosis factor-alpha- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells. Mol. Pharmacol. 58: 526-534
28. Masferrer, J. L., Reddy, S. T., Zweifel, B. S., Seibert, K., Needleman, P., Gilbert, R. S., Herschman, H. R. (1994) In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J. Pharmacol. Exp. Ther. 270: 1340-1344
29. Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M., Currie, M. G. (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214: 11-16
30. Moroney, M. A., Alcaraz, M. J., Forder, R. A., Carey, F., Hoult, J. R. S. (1988) Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavnoids. J. Pharm. Pharmacol. 40: 787-792
31. Pahl, H. L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866
32. Pennanen, N., Lapinjoki, S., Palander, A., Urtti, A., Monkkonen, J. (1995) Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int. J. Immunopharmacol. 17: 475-480
33. Pimentel-Muiños, F. X., Muñoz-Fernández, M. A., Fresno, M. (1994) Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152: 5714-5722
34. Posadas, I., Terencio, M. C., Guillén, I., Ferrándiz, M. L., Coloma, J., Payá, M., Alcaraz, M. J. (2000) Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn Schmiedebergs Arch. Pharmacol. 361: 98-106
35. Rioja, I., Terencio, M. C., Ubeda, A., Molina, P., Tárraga, A., González-Tejero, A., Alcaraz, M. J. (2002) A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxigenase. Eur. J. Pharmacol. 434: 177-185
36. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., Isakson, P. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91: 12 013-12 017
37. Suzuki, K., Ota, H., Sasagawa, S., Sakatani, T., Fujikura, T. (1983) Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132: 345-352
38. Taurog, J. D., Argentieri, D. C., McReynolds, R. A. (1988) Adjuvant arthritis. Methods Enzymol. 162: 339-355
39. Vane, J. R., Mitchell, J. A., Appleton, I., Tomlison, A., Bishop-Bailey, D., Croxtall, J., Willoughby, D. A. (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91: 2046-2050
40. Wang, B., Fijisawa, H., Zhuang, L., Freed, I., Howell, B. G., Shahid, S., Shivji, G. M., Mak, T. W., Sauder, D. N. (1996) CD4(+) Th1 and CD8(+) type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790
41. Yamamoto, T., Nozaki-Taguchi, N. (1996) Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non selective COX inhibitor and NS-398, a COX-2 selective inhibitor. Brain Res. 739: 104-110